ARRAY BIOPHARMA
  
 
Investor Relations Home  |   News   |   Events & Webcasts  |   SEC Filings & Reports  |   Stock Info  |   Analyst Coverage  |   Fundamentals  |   Earnings Estimates  |   FAQs  |   Information Request  |   Financial Tearsheet  |   Corporate Governance
 

Webcast ImageWebcast - Replay
Array BioPharma Inc. at Bank of America Merrill Lynch Health Care Conference
05/16/13 at 11:20 p.m. PT
Receive E-mail AlertsE-mail Alerts
RSS Feeds RSS
Keyword Search
 
2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
 
12/11/11ARRY-614 Demonstrates Positive Single Agent Activity in Patients with Myelodysplastic SyndromesPrinter Friendly Version
12/11/11ARRY-520 Demonstrates Durable Single-Agent Activity in Patients with Advanced Multiple MyelomaPrinter Friendly Version
12/01/11Array BioPharma to Host Analyst and Investor Day Featuring Distinguished Clinical InvestigatorsPrinter Friendly Version
11/29/11Array Biopharma to Present Clinical Data on ARRY-520, a KSP Inhibitor, and ARRY-614, a Dual p38/Tie2 Inhibitor, at the 2011 American Society of Hematology Annual MeetingPrinter Friendly Version
11/17/11Array BioPharma to Present at the Piper Jaffray Health Care ConferencePrinter Friendly Version
10/31/11Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2012Printer Friendly Version
10/24/11Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2012 on October 31, 2011Printer Friendly Version
09/30/11Topline Results:A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung CancerPrinter Friendly Version
09/13/11Array BioPharma to Present at the UBS Global Life Sciences ConferencePrinter Friendly Version
09/08/11Array BioPharma Names Karsten Witt, M.D., Vice President of Clinical SciencesPrinter Friendly Version
08/29/11Array BioPharma to Present at the Stifel Nicolaus Healthcare Conference and the Rodman & Renshaw Global Investment ConferencePrinter Friendly Version
08/08/11Array BioPharma Reports Results for the Fourth Quarter and Full Year of Fiscal 2011Printer Friendly Version
08/08/11Array Announces New Oncology Agreement with GenentechPrinter Friendly Version
08/04/11Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2011 on August 8, 2011Printer Friendly Version
07/13/11Array BioPharma Licenses Cancer Drug ARRY-543 to ASLAN PharmaceuticalsPrinter Friendly Version
06/13/11Array BioPharma Announces RestructuringPrinter Friendly Version
05/31/11Array BioPharma to Present at the Jefferies 2011 Global HealthcareConferencePrinter Friendly Version
05/02/11Array BioPharma Announces $30 Million Debt Reduction and a Loan Term Extension to 2015 and 2016Printer Friendly Version
05/02/11Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2011Printer Friendly Version
04/25/11Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2011 on May 2, 2011Printer Friendly Version
04/07/11Array BioPharma Achieves $10 Million Clinical Milestone in MEK162 Oncology ProgramPrinter Friendly Version
04/01/11Array BioPharma Announces Five Abstracts Selected for Presentation at 2011 AACR Annual MeetingPrinter Friendly Version
03/29/11Array BioPharma to Present at the Leerink Swann Cancer RoundtableConferencePrinter Friendly Version
03/08/11Array BioPharma to Present at the Roth 23rd Annual OC Growth Stock Conference and the Barclay's Capital 2011 Global Healthcare ConferencePrinter Friendly Version
02/28/11Array BioPharma to Present at the Cowen and Company 31st Annual Health Care ConferencePrinter Friendly Version
01/31/11Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2011Printer Friendly Version
01/24/11Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2011 on January 31, 2011Printer Friendly Version
01/04/11Array BioPharma to Present at the 29th Annual J.P. Morgan Healthcare ConferencePrinter Friendly Version

  Printer friendly version

Stock Quote
ARRY (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$5.89
Change (%) Stock is Up 0.20 (3.51%)
Volume912,437
Data as of 05/17/13 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock chart for: 03NA000000ARRY